Email Print Share
June 1, 2015

Silk to enhance stability of vaccines, biotherapeutics and diagnostics.

The NSF-funded small business Vaxess Technologies uses silk to enhance stability of vaccines, biotherapeutics and diagnostics so they can be stored and shipped without refrigeration, reducing the need for the cold chain. Vaxess is one of nearly 40 NSF grantees participating in the 2015 BIO Innovation Zone, an exhibit space dedicated to businesses with cutting-edge biomedical technologies supported by NSF's Directorate for Engineering.

Credit: Vaxess Technologies Inc.


Images credited to the National Science Foundation, a federal agency, are in the public domain. The images were created by employees of the United States Government as part of their official duties or prepared by contractors as "works for hire" for NSF. You may freely use NSF-credited images and, at your discretion, credit NSF with a "Courtesy: National Science Foundation" notation.

Additional information about general usage can be found in Conditions.

Also Available:
Download the high-resolution JPG version of the image. (1.4 MB)

Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.

Related story: A buffet of emerging biotech at 2015 BIO Innovation Zone